Safety Experts to Review AstraZeneca Vaccine

After several European countries halted Oxford/AstraZeneca vaccine rollouts due to development of blood clots, the World Health Organization has assigned a team of experts to review the vaccine.

The Killid Group
16 Mar 2021
Safety Experts to Review AstraZeneca Vaccine
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

WHO’s vaccine safety experts are meeting Tuesday, according to media reports.

Europe reported several cases of blood clots developing after the vaccine was administered.

The European Medicines Agency (EMA) is also meeting on Tuesday, March 16.

The agency is expected to issue its decision whether to continue the use of the Oxford-AstraZeneca vaccine on Thursday.

Nearly 17 million people in the European Union States and the United Kingdom have been inoculated with a dose of the vaccine.

Fewer than 40 cases of blood clots were reported as of last week, according to AstraZeneca.

(Inputs from the BBC)

Follow TKG on Twitter & Facebook
Design & Developed by Techsharks - Copyright © 2021

Copyright 2020 © TKG: A public media project of DHSA